Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oleiferoside A is an oleanane-type triterpenoid saponin isolated from the roots of *Camellia oleifera* (the tea-oil tree). Its chemical structure is characterized by an oleanane-type aglycone with specific sugar moieties attached at the C-3 position. Research into oleiferoside A has primarily focused on its potential antineoplastic properties. In vitro studies using MTT assays have demonstrated that the compound possesses moderate cytotoxic activity against various human tumor cell lines, including A549 (lung cancer), B16 (melanoma), BEL-7402 (liver cancer), and MCF-7 (breast cancer). It is one of several saponins (oleiferosides A-H) discovered in this plant species, contributing to the understanding of the bioactive constituents of *Camellia oleifera*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oleiferoside A.